NAD+ Injections: The Science Behind the Most-Hyped Longevity Therapy

NAD+ has been one of the most hyped molecules in longevity medicine for the past decade, and for once, the hype has actual science behind it. Nicotinamide adenine dinucleotide is not a peptide, not a hormone, and not a vitamin in the traditional sense. It is a coenzyme present in every cell of your body, required for over 500 enzymatic reactions, and absolutely critical for mitochondrial function and cellular energy production [1].

The catch: NAD+ levels decline dramatically with age. Studies show NAD+ drops by approximately 50% between ages 30 and 60, with continued decline thereafter [2]. The question of NAD+ therapy is whether restoring those levels can restore some of what was lost, and the evidence increasingly says yes.

What Is NAD+?

NAD+ stands for nicotinamide adenine dinucleotide (oxidized form). It is built from niacin (vitamin B3) plus other building blocks your body assembles. Every cell in your body uses NAD+ as the central currency for two critical functions:

• Energy metabolism: NAD+ shuttles electrons through the mitochondrial electron transport chain, the system that converts glucose and fatty acids into ATP, the energy currency of all cells.
• DNA repair and signaling: NAD+ is the substrate for sirtuins (SIRT1-7) and PARP enzymes, the proteins responsible for DNA damage repair, gene expression regulation, and cellular stress response [3].

When NAD+ runs low, both of these systems falter. Mitochondria produce less energy. DNA damage accumulates. Sirtuins go offline. The cell behaves like an old cell because, in NAD+ terms, it is.

Why NAD+ Declines With Age

Three mechanisms drive the age-related decline:

• Reduced production: The enzymes that synthesize NAD+ become less efficient with age, particularly NAMPT (nicotinamide phosphoribosyltransferase) [1].
• Increased consumption: Chronic low-grade inflammation activates CD38 and PARP enzymes that consume NAD+ at higher rates than in young cells.
• Reduced precursor availability: Dietary niacin and tryptophan, the building blocks of NAD+, are not always sufficient to keep up with demand.

The downstream consequences are precisely what we associate with aging: declining energy, slower recovery, mitochondrial dysfunction, accumulating DNA damage, reduced metabolic flexibility, and decreased stress resilience.

What NAD+ Restoration Does

Animal studies have shown striking effects from NAD+ restoration. In mice, long-term NAD+ precursor supplementation improved insulin sensitivity, mitochondrial function, exercise capacity, and lifespan-related markers [4]. The effects were most pronounced in older animals, where baseline NAD+ was lowest.

Human trials are catching up. A randomized controlled trial of nicotinamide riboside (an oral NAD+ precursor) in middle-aged and older adults showed significantly elevated NAD+ levels with good tolerability over 6 weeks [5]. Other trials have shown improvements in:

• Energy and fatigue scores
• Mitochondrial respiration in muscle biopsies
• Markers of inflammation
• Cardiovascular markers (blood pressure, arterial stiffness in some studies)
• Cognitive performance in older adults

The effect sizes vary by study, age group, and baseline status. The clearest pattern: lower baseline NAD+ predicts greater response to restoration.

Routes of NAD+ Therapy

IV Infusion

The most aggressive route. NAD+ is infused over 2 to 4 hours at doses ranging from 250 mg to 1000 mg per session. Bioavailability is essentially 100% (it bypasses the digestive system). The downside: most patients experience flushing, nausea, or chest tightness during high-dose infusion, requiring slow drip rates. IV NAD+ also carries a higher cost ($300-$1000 per session) and requires clinical supervision.

Subcutaneous Injection

The middle ground. NAD+ injected subcutaneously delivers high bioavailability without the infusion-time investment. Typical protocols use 100 to 250 mg per injection, 2 to 5 times per week. Self-administered after initial training. This is the most practical route for ongoing therapy.

Nasal Spray

An emerging option for patients seeking rapid CNS effects (cognitive performance, mood, focus). The intranasal route bypasses systemic metabolism and delivers NAD+ closer to the brain. Lower total dose, more targeted effect.

Oral NAD+ Precursors

Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are oral precursors that your body converts into NAD+. Less direct than NAD+ itself but easier to take. The clinical question is conversion efficiency: how much actually reaches NAD+ vs being shunted elsewhere. The trial data for NR is the strongest of the oral options [5].

What Patients Report

Common subjective effects from sustained NAD+ therapy:

• Energy: Most consistent report. Patients describe steadier energy throughout the day, less mid-afternoon crash, easier mornings.
• Mental clarity: Improved focus, faster mental processing, better verbal recall.
• Recovery: Faster recovery from exercise and physical exertion. Older athletes report measurable training capacity gains.
• Sleep quality: Deeper sleep, more vivid dreams (likely reflecting REM improvement).
• Stress resilience: Greater capacity to handle stressors without the fatigue crash.

What NAD+ does not consistently do: dramatic weight loss, anti-aging cosmetic effects, or curing specific diseases. It works at the cellular substrate level. The effects accumulate gradually and show up as overall function rather than a single dramatic outcome.

Dosing Protocols

Most clinical protocols start with a "loading phase" of 4 to 8 weeks at the higher end of the range, then transition to maintenance dosing. The loading phase is when patients tend to notice the largest subjective changes; maintenance preserves them.

Side Effects and Safety

NAD+ therapy is generally well-tolerated. The most common issues are:

• Flushing during IV: Warm sensation, redness, mild nausea, caused by rapid niacin-pathway activation. Slowing the drip rate resolves it.
• Injection site reactions: Mild redness or swelling for SC route, transient.
• Nausea: More common with IV; rare with SC.
• Headache: Mild, usually in the first week of therapy.

NAD+ is contraindicated or requires caution in:

• Active cancer (theoretical concern: NAD+ supports cell proliferation; the data on whether this accelerates or inhibits cancer is mixed and insufficient)
• Pregnancy or breastfeeding
• Severe liver or kidney impairment

Who Should Consider NAD+ Therapy?

The strongest candidates:

• Adults 40+ noticing energy decline, slower recovery, or fatigue not explained by other conditions
• Athletes seeking improved training capacity and recovery, particularly older athletes
• Patients with chronic fatigue presentations
• Patients pursuing comprehensive longevity protocols
• Recovery from intensive periods (illness, overtraining, high-stress life events)

Less appropriate for:

• Patients expecting cosmetic anti-aging effects (this is cellular, not surface)
• Anyone unwilling to commit to consistent dosing for at least 8 weeks
• Patients who have not addressed sleep, exercise, and nutrition basics first

What to Look for in a NAD+ Provider

The market has flooded with NAD+ clinics of varying quality. Markers of legitimate practice:

• Real medical evaluation: Comprehensive intake, baseline labs (including basic metabolic panel and liver function), discussion of goals and contraindications.
• Pharmaceutical-grade NAD+: Sourced from a 503A or 503B compounding pharmacy with proper licensing and certificates of analysis. Not "research grade" or international gray-market product.
• Honest evidence discussion: Clear about what the data supports vs what is extrapolation from animal studies.
• Sensible protocols: Not the highest dose, fastest infusion, or maximum frequency for marketing purposes.
• Follow-up plan: Monitoring response, adjusting dose, periodic labs.

The Honest Limitations

The science is real but still evolving. Important caveats:

• Most lifespan/healthspan data is in animal models; long-term human outcome studies are still in progress.
• The mechanisms operate at the cellular level. Patients expecting transformative external changes may be disappointed.
• NAD+ does not undo damage that is already done. It supports better function from your current baseline.
• The therapy is more like a long-term metabolic foundation than a quick intervention. Discontinuing erodes the gains.

Bottom Line

NAD+ therapy targets one of the most fundamental aging mechanisms we currently understand. The molecule is essential for the cellular function that erodes most predictably with age, and restoration produces measurable improvements in mitochondrial function, sirtuin activity, and patient-reported outcomes.

It is not a cure for aging or a replacement for the lifestyle fundamentals. But for patients pursuing comprehensive longevity, recovering from chronic depletion, or dealing with age-related energy decline, NAD+ is one of the most evidence-supported interventions currently available.

The patients who get the best results treat it as a long-term metabolic foundation: consistent dosing, periodic protocol review, integration with sleep, exercise, and nutrition, and realistic expectations about timeline. The cellular changes happen first; the subjective improvements compound over weeks.